TERNS PHARMACEUTICALS
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets. Based in San Mateo, California and Shanghai, Terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in China and globally.
TERNS PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Founded:
2016-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.ternspharma.com
Total Employee:
11+
Status:
Active
Total Funding:
262 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Current Employees Featured
Founder
Stock Details
Investors List
Fairmount Funds Management
Fairmount Funds Management investment in Post-IPO Equity - Terns Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Terns Pharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Terns Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series C - Terns Pharmaceuticals
Deerfield
Deerfield investment in Series C - Terns Pharmaceuticals
Suvretta Capital Management
Suvretta Capital Management investment in Series C - Terns Pharmaceuticals
Samara Capital
Samara Capital investment in Series C - Terns Pharmaceuticals
Eli Lilly
Eli Lilly investment in Series C - Terns Pharmaceuticals
OrbiMed
OrbiMed investment in Series C - Terns Pharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Terns Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.ternspharma.com Semrush global rank: 5.09 M Semrush visits lastest month: 1.61 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013